Chapter VIII RISK-MITIGATION TECHNIQUES FOR OTC DERIVATIVE CONTRACTS NOT CLEARED BY A CCP
United Kingdom
- 12(Article 11(14)(a) of Regulation (EU) No 648/2012)Timely confirmation
- 13(Article 11(14)(a) of Regulation (EU) No 648/2012)Portfolio reconciliation
- 14(Article 11(14)(a) of Regulation (EU) No 648/2012)Portfolio compression
- 15(Article 11(14)(a) of Regulation (EU) No 648/2012)Dispute resolution
- 16(Article 11(14)(b) of Regulation (EU) No 648/2012)Market conditions that prevent marking-to-market
- 17(Article 11(14)(b) of Regulation (EU) No 648/2012)Criteria for using marking-to-model
- 18(Article 11(14)(c) of Regulation (EU) No 648/2012)Details of the intragroup transaction notification to the competent authority
- 19(Article 11(14)(d) of Regulation (EU) No 648/2012)Details of the intragroup transaction notification to ESMA
- 20(Article 11(14)(d) of Regulation (EU) No 648/2012)Information on the intragroup exemption to be publicly disclosed
- 21Entry into force and application